Document Detail

Effects of physical exercise versus rosiglitazone on endothelial function in coronary artery disease patients with prediabetes.
MedLine Citation:
PMID:  20649635     Owner:  NLM     Status:  In-Process    
We conducted a three-arm, parallel-group, randomized, controlled trial to compare the effects of rosiglitazone and physical exercise on endothelial function in patients with coronary artery disease and impaired fasting glucose or impaired glucose tolerance over a 6-month period. Group A received rosiglitazone tablets 8 mg daily (n = 16), group B underwent a structured physical exercise programme (n = 15) and group C served as a control group (n = 12). At baseline and after 6 months, brachial artery ultrasound imaging was performed to assess reactive flow-mediated dilation (FMD). Rosiglitazone treatment and exercise both led to significant improvements in insulin resistance at 6 months, whereas no change was observed in control patients. FMD improved significantly in physical exercise patients, whereas no change could be observed in patients receiving rosiglitazone or in the control group. Between-group comparisons also showed a significant relative improvement in FMD in exercise patients compared with rosiglitazone.
S Desch; M Sonnabend; J Niebauer; S Sixt; M Sareban; I Eitel; S de Waha; H Thiele; M Blüher; G Schuler
Related Documents :
20299615 - Short-term exercise training prevents micro- and macrovascular disease following corona...
856545 - Systolic time intervals before and after maximal exercise treadmill testing for evaluat...
7342465 - A computer terminal program to evaluate cardiovascular functional limits and estimate c...
8512675 - Cardiac precautions for non-acute inpatient settings.
22298655 - Physical activity and exercise in the regulation of human adipose tissue physiology.
2746165 - Sensitive analysis of retinyl esters by isocratic adsorption chromatography.
Publication Detail:
Type:  Letter    
Journal Detail:
Title:  Diabetes, obesity & metabolism     Volume:  12     ISSN:  1463-1326     ISO Abbreviation:  Diabetes Obes Metab     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-07-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883645     Medline TA:  Diabetes Obes Metab     Country:  England    
Other Details:
Languages:  eng     Pagination:  825-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: p...
Next Document:  Niche conservatism as an emerging principle in ecology and conservation biology.